Condition: Healthy Volunteers · Sponsor: Mirum Pharmaceuticals, Inc.
This is a Phase 1, open label study in healthy male participants to study the Absorption, Distribution, Metabolism, and Excretion of \[14C\]-MRM-3379 drug following a single oral dose.
This description comes directly from the study's public registry record.
Clinical Trials Mirum · +16506674085 · Clinicaltrials@mirumpharma.com
Medinfo Mirum · medinfo@mirumpharma.com
Always discuss trial participation with your own doctor first.
| Fortrea Clinical Research Unit Inc | Madison, Wisconsin, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07712718